Mar 14, 2023 / 07:00PM GMT
Kumar Raja - ROTH Capital Partners - Analyst
Good afternoon and thanks for joining us. I am Kumar Raja, senior biotech analyst at ROTH MKM. The next company presenting is Adial Pharmaceuticals. We have Cary Claiborne, who is the President and CEO of the company. Welcome, Cary.
Cary Claiborne - Adial Pharmaceuticals, Inc. - COO
Thanks a lot, Kumar. Thanks to everyone for having me.
Kumar Raja - ROTH Capital Partners - Analyst
Maybe we can just get started by getting an overview of the company.
Cary Claiborne - Adial Pharmaceuticals, Inc. - COO
Sure. So Adial is a company that's focused on treating addiction. Our primary focus is treating alcohol use disorder, which is a major public health crisis in America, with over 35 million people suffering from alcohol use disorder.
It's actually the leading cause of death between people aged 15 to 49 and is a leading risk factor for over 200 diseases. Over 31% of vehicle fatalities are associated with alcohol. So it's a major
Adial Pharmaceuticals Inc at ROTH Conference Transcript
Mar 15, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers